Determination of Genes Related to Uveitis by Utilization of the Random Walk with Restart Algorithm on a Protein–Protein Interaction Network

Uveitis, defined as inflammation of the uveal tract, may cause blindness in both young and middle-aged people. Approximately 10–15% of blindness in the West is caused by uveitis. Therefore, a comprehensive investigation to determine the disease pathogenesis is urgent, as it will thus be possible to design effective treatments. Identification of the disease genes that cause uveitis is an important requirement to achieve this goal. To begin to answer this question, in this study, a computational method was proposed to identify novel uveitis-related genes. This method was executed on a large protein–protein interaction network and employed a popular ranking algorithm, the Random Walk with Restart (RWR) algorithm. To improve the utility of the method, a permutation test and a procedure for selecting core genes were added, which helped to exclude false discoveries and select the most important candidate genes. The five-fold cross-validation was adopted to evaluate the method, yielding the average F1-measure of 0.189. In addition, we compared our method with a classic GBA-based method to further indicate its utility. Based on our method, 56 putative genes were chosen for further assessment. We have determined that several of these genes (e.g., CCL4, Jun, and MMP9) are likely to be important for the pathogenesis of uveitis.

[1]  C. Egwuagu,et al.  SOCS3 Deletion in T Lymphocytes Suppresses Development of Chronic Ocular Inflammation via Upregulation of CTLA-4 and Expansion of Regulatory T Cells , 2013, The Journal of Immunology.

[2]  Ping Zhang,et al.  [In vivo effect of recombined IL-15/Fc fusion protein on EAU]. , 2008, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[3]  Kuo-Chen Chou,et al.  Predicting Functions of Proteins in Mouse Based on Weighted Protein-Protein Interaction Network and Protein Hybrid Properties , 2011, PloS one.

[4]  A. Urayama,et al.  [A nation-wide survey on the occurrence of Vogt-Koyanagi-Harada disease in Japan]. , 1994, Nippon Ganka Gakkai zasshi.

[5]  Justine R. Smith,et al.  Intercellular adhesion molecule 1 mediates migration of Th1 and Th17 cells across human retinal vascular endothelium. , 2013, Investigative ophthalmology & visual science.

[6]  S. Miller,et al.  Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. , 1999, The Journal of clinical investigation.

[7]  G. Opdenakker,et al.  The Cytokine Interleukin-6 and the Chemokines CCL20 and CXCL13 Are Novel Biomarkers of Specific Endogenous Uveitic Entities. , 2016, Investigative ophthalmology & visual science.

[8]  R. Nussenblatt,et al.  Gene Expression Profiling in Autoimmune Noninfectious Uveitis Disease1 , 2008, The Journal of Immunology.

[9]  James R. Woodgett,et al.  Phosphorylation of c-jun mediated by MAP kinases , 1991, Nature.

[10]  H. Grossniklaus,et al.  Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome , 2017, Ocular immunology and inflammation.

[11]  A. Kijlstra,et al.  IL-23R gene confers susceptibility to Behcet's disease in a Chinese Han population , 2010, Annals of the rheumatic diseases.

[12]  E Stuber,et al.  Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion , 1996, The Journal of experimental medicine.

[13]  D. Wakefield,et al.  Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease , 2005, British Journal of Ophthalmology.

[14]  Yu-Dong Cai,et al.  Identifying novel protein phenotype annotations by hybridizing protein–protein interactions and protein sequence similarities , 2016, Molecular Genetics and Genomics.

[15]  R J Armitage,et al.  Structural characteristics of CD40 ligand that determine biological function. , 1994, Seminars in immunology.

[16]  S. Yeh,et al.  Vogt-Koyanagi-Harada-like syndrome after CTLA-4 inhibition with ipilimumab for metastatic melanoma. , 2015, Journal of immunotherapy.

[17]  S. Ohno,et al.  Association of the toll-like receptor 4 gene polymorphisms with Behçet’s disease , 2007, Annals of the rheumatic diseases.

[18]  M. Fini,et al.  MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology , 2002, Progress in Retinal and Eye Research.

[19]  Yu-Dong Cai,et al.  Identification of novel candidate drivers connecting different dysfunctional levels for lung adenocarcinoma using protein-protein interactions and a shortest path approach , 2016, Scientific Reports.

[20]  A. Kijlstra,et al.  IL-1β triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROS-NLRP3 inflammasome-dependent pathways is involved in ocular Behçet's disease. , 2013, Investigative ophthalmology & visual science.

[21]  G. Cheung,et al.  Aqueous cytokine and chemokine analysis in uveitis associated with tuberculosis , 2012, Molecular vision.

[22]  C. Chan,et al.  Suppressive effect of transforming growth factor beta1 on the recurrence of experimental melanin protein-induced uveitis: upregulation of ocular interleukin-10. , 1996, Clinical immunology and immunopathology.

[23]  S. Pešić,et al.  Two cases of uveitis masquerade syndrome caused by bilateral intraocular large B-cell lymphoma. , 2013, Vojnosanitetski pregled.

[24]  E. Krogh,et al.  Increased CD40 ligand in patients with acute anterior uveitis. , 2005, Acta ophthalmologica Scandinavica.

[25]  M. Naud,et al.  The effects of intraocular injection of interleukin-13 on endotoxin-induced uveitis in rats. , 2001, Investigative ophthalmology & visual science.

[26]  A. F. Campese,et al.  Activation of an endothelial Notch1-Jagged1 circuit induces VCAM1 expression, an effect amplified by interleukin-1β , 2015, Oncotarget.

[27]  G. Feldman,et al.  STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. , 1997, Blood.

[28]  A. Kijlstra,et al.  HLA typing in birdshot chorioretinopathy. , 1988, American journal of ophthalmology.

[29]  Kuo-Chen Chou,et al.  Deciphering the effects of gene deletion on yeast longevity using network and machine learning approaches. , 2012, Biochimie.

[30]  A. Vitale,et al.  Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art , 2016, Clinical Rheumatology.

[31]  E. Miserocchi,et al.  New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient. , 2015, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[32]  Yi-Ting Fang,et al.  Annexin A2 Silencing Induces G2 Arrest of Non-small Cell Lung Cancer Cells through p53-dependent and -independent Mechanisms* , 2012, The Journal of Biological Chemistry.

[33]  Y. Itoyama,et al.  Chemokine profile in the cerebrospinal fluid and serum of Vogt–Koyanagi–Harada disease , 2005, Journal of Neuroimmunology.

[34]  T. Gilliam,et al.  Molecular triangulation: bridging linkage and molecular-network information for identifying candidate genes in Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Lei Chen,et al.  Application of the Shortest Path Algorithm for the Discovery of Breast Cancer-Related Genes , 2016 .

[36]  Rui Jiang,et al.  Constructing a gene semantic similarity network for the inference of disease genes , 2011, BMC Systems Biology.

[37]  F. Roberge,et al.  Treatment of uveitis with recombinant human interleukin-13 , 1998, The British journal of ophthalmology.

[38]  Alexander F. Wilson,et al.  Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease , 2013, Proceedings of the National Academy of Sciences.

[39]  A. Miyajima,et al.  Interleukin‐3, granulocyte‐macrophage colony‐stimulating factor, and interleukin‐5 transduce signals through two forms of STAT5 , 1995, Journal of leukocyte biology.

[40]  G. Levy-Clarke,et al.  Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation. , 2011, Investigative ophthalmology & visual science.

[41]  A. Tari,et al.  Cyclooxygenase-2 utilizes Jun N-terminal kinases to induce invasion, but not tamoxifen resistance, in MCF-7 breast cancer cells. , 2013, Oncology reports.

[42]  Tao Huang,et al.  Identification of compound–protein interactions through the analysis of gene ontology, KEGG enrichment for proteins and molecular fragments of compounds , 2016, Molecular Genetics and Genomics.

[43]  Jinyan Li,et al.  Disease gene identification by random walk on multigraphs merging heterogeneous genomic and phenotype data , 2012, BMC Genomics.

[44]  F. Shahram,et al.  Association of interleukin-2, interleukin-4 and transforming growth factor-beta gene polymorphisms with Behcet's disease. , 2011, Clinical and experimental rheumatology.

[45]  H. Inoko,et al.  Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci , 2010, Nature Genetics.

[46]  S. Seregard,et al.  Uveitis masquerade syndromes: diffuse retinoblastoma in an older child. , 2007, Acta ophthalmologica Scandinavica.

[47]  M. Jücker,et al.  Identification of a New Adapter Protein That May Link the Common β Subunit of the Receptor for Granulocyte/Macrophage Colony-stimulating Factor, Interleukin (IL)-3, and IL-5 to Phosphatidylinositol 3-Kinase (*) , 1995, The Journal of Biological Chemistry.

[48]  J. Shimizu,et al.  Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease. , 2012, Clinical and experimental rheumatology.

[49]  M. Kaplan,et al.  STAT6-mediated keratitis and blepharitis: a novel murine model of ocular atopic dermatitis. , 2014, Investigative ophthalmology & visual science.

[50]  I. Süveges,et al.  Vogt‐Koyanagi‐Harada syndrome , 1993, Acta ophthalmologica.

[51]  Philipp S. Hoppe,et al.  The transcription factors STAT5A/B regulate GM-CSF-mediated granulopoiesis. , 2009, Blood.

[52]  E. Shaulian AP-1--The Jun proteins: Oncogenes or tumor suppressors in disguise? , 2010, Cellular signalling.

[53]  Javier Martín,et al.  Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition , 2013, BMC Medical Genetics.

[54]  Justine R. Smith,et al.  Protein Kinase Cζ (PKCζ) Regulates Ocular Inflammation and Apoptosis in Endotoxin-Induced Uveitis (EIU): Signaling Molecules Involved in EIU Resolution by PKCζ Inhibitor and Interleukin-13 , 2007 .

[55]  M. Karin,et al.  Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73 , 1992, Molecular and cellular biology.

[56]  A. Aruffo,et al.  CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. , 1992, Immunology today.

[57]  F. Bandello,et al.  Review on the Worldwide Epidemiology of Uveitis , 2013, European journal of ophthalmology.

[58]  E. Lee,et al.  Association between matrix metalloproteinase 9 promoter polymorphisms and Behçet's disease. , 2010, Human immunology.

[59]  S. Androudi Current concepts in the etiology and treatment of Behçet disease. , 2006, Survey of ophthalmology.

[60]  Dongseok Choi,et al.  Unique gene expression profiles of donor-matched human retinal and choroidal vascular endothelial cells. , 2007, Investigative ophthalmology & visual science.

[61]  Jagdish Chandra Patra,et al.  Genome-wide inferring gene-phenotype relationship by walking on the heterogeneous network , 2010, Bioinform..

[62]  D. Wakefield,et al.  Expression of toll-like receptor 4 and its associated lipopolysaccharide receptor complex by resident antigen-presenting cells in the human uvea. , 2004, Investigative ophthalmology & visual science.

[63]  P. Leder,et al.  IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice , 1990, Cell.

[64]  Christian von Mering,et al.  STRING 8—a global view on proteins and their functional interactions in 630 organisms , 2008, Nucleic Acids Res..

[65]  H. Nagase,et al.  Progress in matrix metalloproteinase research. , 2008, Molecular aspects of medicine.

[66]  D. Gray,et al.  Activated human T cells express a ligand for the human B cell‐associated antigen CD40 which participates in T cell‐dependent activation of B lymphocytes , 1992, European journal of immunology.

[67]  E. Chiffoleau,et al.  Impaired Notch4 Activity Elicits Endothelial Cell Activation and Apoptosis: Implication for Transplant Arteriosclerosis , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[68]  D. Wakefield,et al.  Uveitis: a global perspective , 2002, Ocular immunology and inflammation.

[69]  Justine R. Smith,et al.  Hypothesis: sarcoidosis is a STAT1-mediated disease. , 2009, Clinical immunology.

[70]  Christopher I. Amos,et al.  Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R/IL12RB2 regions associated with Behçet's disease , 2010, Nature Genetics.

[71]  Hong Qi,et al.  Jun activation domain-binding protein 1 expression in oral squamous cell carcinomas inversely correlates with the cell cycle inhibitor p27 , 2012, Medical Oncology.

[72]  N. Sachdeva,et al.  Role of Regulatory T Cells in Tubercular Uveitis , 2018, Ocular immunology and inflammation.

[73]  H. Sekine,et al.  Association of the toll-like receptor 9 gene polymorphisms with Behcet's disease in a Japanese population. , 2012, Fukushima journal of medical science.

[74]  Akira Meguro,et al.  Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1 , 2013, Nature Genetics.

[75]  S. Taheri,et al.  mRNA Expression Level of Interleukin Genes in the Determining Phases of Behçet's Disease , 2015, Annals of dermatology.

[76]  H. Weiner,et al.  Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Zhen Wang,et al.  Identification of Hepatocellular Carcinoma-Related Genes with a Machine Learning and Network Analysis , 2015, J. Comput. Biol..

[78]  A. Kijlstra,et al.  Association of TLR2 gene polymorphisms with ocular Behcet's disease in a Chinese Han population. , 2013, Investigative ophthalmology & visual science.

[79]  Gillian Murphy,et al.  Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.

[80]  B. Snel,et al.  Predicting disease genes using protein–protein interactions , 2006, Journal of Medical Genetics.

[81]  A. Kijlstra,et al.  Association Between Copy Number Variations of TLR7 and Ocular Behçet's Disease in a Chinese Han Population. , 2015, Investigative ophthalmology & visual science.

[82]  N. Akar,et al.  Behçet's: A Disease or a Syndrome? Answer from an Expression Profiling Study , 2016, PloS one.

[83]  L. Bradbury,et al.  Genetic Dissection of Acute Anterior Uveitis Reveals Similarities and Differences in Associations Observed With Ankylosing Spondylitis , 2015, Arthritis & rheumatology.

[84]  A. Kijlstra,et al.  Berberine suppresses Th17 and dendritic cell responses. , 2013, Investigative ophthalmology & visual science.

[85]  Stian Sjøli,et al.  Biological and Pathobiological Functions of Gelatinase Dimers and Complexes , 2008, Connective tissue research.

[86]  Song Chen,et al.  Subretinal transfection of chitosan-loaded TLR3-siRNA for the treatment of experimental autoimmune uveitis. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[87]  I. Stamenkovic,et al.  The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co‐stimulatory activity. , 1992, The EMBO journal.

[88]  Y. Lee,et al.  Toll-like receptor polymorphisms and vasculitis susceptibility: meta-analysis and systematic review , 2012, Molecular Biology Reports.

[89]  P. Robinson,et al.  Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.

[90]  Y. Pei,et al.  Effect of glucocorticoid on cytokines TLR9 and TLR7 in peripheral blood for patients with uveitis , 2016, Experimental and therapeutic medicine.

[91]  P. Kulkarni,et al.  Review: uveitis and immunosuppressive drugs. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[92]  Yu-Dong Cai,et al.  Mining for novel tumor suppressor genes using a shortest path approach , 2016, Journal of biomolecular structure & dynamics.

[93]  R. Nussenblatt,et al.  Suppression of immune-mediated ocular inflammation in mice by interleukin 1 receptor antagonist administration. , 2005, Archives of ophthalmology.

[94]  S. Itohara,et al.  S100B Up-Regulates Macrophage Production of IL1β and CCL22 and Influences Severity of Retinal Inflammation , 2015, PloS one.

[95]  M. D. F. D. de Oliveira,et al.  Psoriasis and uveitis: a literature review , 2012, Anais brasileiros de dermatologia.

[96]  Ting-feng Wu,et al.  CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma , 2016, Journal of Cancer.

[97]  Y. Tao,et al.  Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1. , 2004, Cellular signalling.

[98]  R. Nussenblatt,et al.  TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 , 2007, Nature Medicine.

[99]  Yu-Dong Cai,et al.  Gene Ontology and KEGG Enrichment Analyses of Genes Related to Age-Related Macular Degeneration , 2014, BioMed research international.

[100]  N. Yoshimura,et al.  DNA microarray analysis of gene expression in iris and ciliary body of rat eyes with endotoxin-induced uveitis. , 2005, Experimental eye research.

[101]  Kuo-Chen Chou,et al.  Prediction of Body Fluids where Proteins are Secreted into Based on Protein Interaction Network , 2011, PloS one.

[102]  T. Waldmann,et al.  Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[103]  A. Kijlstra,et al.  T-bet expression in the iris and spleen parallels disease expression during endotoxin-induced uveitis , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[104]  Jian Zhang,et al.  Identification of novel proliferative diabetic retinopathy related genes on protein-protein interaction network , 2016, Neurocomputing.

[105]  A. Kijlstra,et al.  Higher Expression of NOD1 and NOD2 is Associated with Vogt-Koyanagi-Harada (VKH) Syndrome But Not Behcet's Disease (BD). , 2016, Current molecular medicine.

[106]  Ron Kohavi,et al.  A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection , 1995, IJCAI.

[107]  R. Jaster,et al.  Rapid activation of the MAP kinase pathway in hematopoietic cells by erythropoietin, granulocyte-macrophage colony-stimulating factor and interleukin-3. , 1994, Cellular signalling.

[108]  J. Choe,et al.  The distinct expressions of interleukin-15 and interleukin-15 receptor α in Behçet’s disease , 2013, Rheumatology International.

[109]  M. Weger,et al.  IL2RA gene polymorphism rs2104286 A>G seen in multiple sclerosis is associated with intermediate uveitis: possible parallel pathways? , 2011, Investigative ophthalmology & visual science.

[110]  C. Sotozono,et al.  Diffuse Anterior Retinoblastoma with Sarcoidosis-Like Nodule , 2015, Case Reports in Ophthalmology.

[111]  D. Charteris,et al.  Comparison of the expression of interferon gamma, IL2, IL4, and lymphotoxin mRNA in experimental autoimmune uveoretinitis. , 1994, The British journal of ophthalmology.

[112]  Q. Shu,et al.  Identification of a susceptibility locus in STAT4 for Behçet's disease in Han Chinese in a genome-wide association study. , 2012, Arthritis and rheumatism.

[113]  Lei Chen,et al.  Analysis of Tumor Suppressor Genes Based on Gene Ontology and the KEGG Pathway , 2014, PloS one.

[114]  R. Flavell,et al.  CD40 and CD154 in cell-mediated immunity. , 1998, Annual review of immunology.

[115]  M. Naud,et al.  Inhibition of endotoxin-induced uveitis and potentiation of local TNF-alpha and interleukin-6 mRNA expression by interleukin-13. , 1999, Investigative ophthalmology & visual science.

[116]  A. Kijlstra,et al.  Genetic variations of IL17F and IL23A show associations with Behçet's disease and Vogt-Koyanagi-Harada syndrome. , 2015, Ophthalmology.

[117]  I. Maclennan,et al.  A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex , 1995, The Journal of experimental medicine.

[118]  B. Jiang,et al.  PAK1-dependent MAPK pathway activation is required for colorectal cancer cell proliferation , 2012, Tumor Biology.